Pfizer Company Profile (NYSE:PFE)

About Pfizer

Pfizer logoPfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. Its portfolio includes medicines, vaccines and medical devices, as well as consumer healthcare products. Its products include Prevnar/Prevenar 13, Lyrica, Enbrel, Lipitor, Viagra, Sutent, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel. Its commercial operations consist of two businesses: Innovative Products business and Established Products business. The Innovative Products business consists of two segments: the Global Innovative Pharmaceutical segment (GIP) and the Global Vaccines, Oncology and Consumer Healthcare segment (VOC). The Established Products business consists of the Global Established Pharmaceutical segment (GEP). Its research focuses on six areas, which include immunology and inflammation, cardiovascular and metabolic diseases, oncology, vaccines, neuroscience and pain, and rare diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: PFE
  • CUSIP: 71708110
Key Metrics:
  • Previous Close: $34.82
  • 50 Day Moving Average: $35.84
  • 200 Day Moving Average: $33.28
  • Trailing P/E Ratio: 30.87
  • Foreward P/E Ratio: 13.09
  • P/E Growth: 2.07
  • Market Cap: $211.21B
  • Outstanding Shares: 6,065,652,000
  • Beta: 0.83
Additional Links:
Companies Related to Pfizer:

Analyst Ratings

Consensus Ratings for Pfizer (NYSE:PFE) (?)
Ratings Breakdown: 9 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.61)
Consensus Price Target: $38.90 (11.70% upside)

Analysts' Ratings History for Pfizer (NYSE:PFE)
DateFirmActionRatingPrice TargetDetails
8/25/2016Jefferies GroupSet Price TargetBuy$40.00View Rating Details
8/22/2016Bank of America Corp.Set Price TargetBuy$40.00View Rating Details
8/23/2016Piper Jaffray Cos.Set Price TargetBuy$54.00View Rating Details
8/23/2016BMO Capital MarketsReiterated RatingOutperform$40.00View Rating Details
8/22/2016Credit Suisse Group AGReiterated RatingOutperform$40.00View Rating Details
8/18/2016Deutsche Bank AGReiterated RatingBuy$44.00View Rating Details
8/3/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00View Rating Details
8/3/2016Citigroup Inc.Reiterated RatingNeutral$37.00View Rating Details
8/2/2016Barclays PLCReiterated RatingEqual Weight$34.00View Rating Details
8/2/2016Sanford C. BernsteinSet Price TargetBuy$38.00View Rating Details
5/17/2016Morgan StanleyReiterated RatingHold$36.00View Rating Details
5/12/2016Berenberg BankInitiated CoverageHold$38.00View Rating Details
5/9/2016Goldman Sachs Group Inc.Set Price TargetNeutral$37.00View Rating Details
5/4/2016Independent Research GmbHSet Price TargetNeutral$37.00View Rating Details
5/4/2016Societe GeneraleSet Price TargetNeutral$34.00View Rating Details
5/2/2016Leerink SwannLower Price TargetMarket Perform$37.00 -> $34.70View Rating Details
4/12/2016S&P Equity ResearchReiterated RatingBuyView Rating Details
2/16/2016SunTrust Banks Inc.Lower Price TargetNeutral$37.00 -> $33.00View Rating Details
2/11/2016ArgusBoost Price TargetBuy$32.00 -> $39.00View Rating Details
1/26/2016Nord/LBReiterated RatingBuyView Rating Details
1/5/2016Atlantic SecuritiesReiterated RatingBuy$39.00View Rating Details
12/2/2015Cowen and CompanyReiterated RatingBuy$43.00View Rating Details
11/24/2015Evercore ISIReiterated RatingBuy$38.00View Rating Details
(Data available from 8/27/2014 forward)


Earnings History for Pfizer (NYSE:PFE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$0.62$0.64$13.01 billion$13.10 billionViewN/AView Earnings Details
5/3/2016Q116$0.55$0.67$12.00 billion$13.00 billionViewN/AView Earnings Details
2/2/2016Q415$0.52$0.53$13.57 billion$14.05 billionViewN/AView Earnings Details
10/27/2015Q315$0.51$0.60$11.56 billion$12.10 billionViewListenView Earnings Details
7/28/2015Q215$0.52$0.56$11.39 billion$11.00 billionViewListenView Earnings Details
4/28/2015Q115$0.49$0.51$10.79 billion$10.86 billionViewN/AView Earnings Details
1/27/2015Q414$0.53$0.54$12.94 billion$13.10 billionViewN/AView Earnings Details
10/28/2014Q314$0.55$0.57$12.24 billion$12.40 billionViewN/AView Earnings Details
7/29/2014Q214$0.57$0.58$12.49 billion$12.80 billionViewN/AView Earnings Details
5/5/2014Q114$0.56$0.57$12.07 billion$11.35 millionViewN/AView Earnings Details
1/27/2014Q413$0.52$0.56$13.35 billion$13.56 billionViewN/AView Earnings Details
10/29/2013Q313$0.56$0.58$12.69 billion$12.64 billionViewN/AView Earnings Details
7/30/2013Q2 2013$0.55$0.56$13.02 billion$12.97 billionViewListenView Earnings Details
4/30/2013Q1 2013$0.55$0.54$14.10 billion$13.50 billionViewListenView Earnings Details
1/29/2013Q4 2012$0.44$0.47$14.40 billion$15.10 billionViewListenView Earnings Details
11/1/2012Q312$0.53$0.53$14.64 billion$14.00 billionViewN/AView Earnings Details
7/31/2012$0.54$0.62ViewN/AView Earnings Details
5/1/2012$0.57$0.58ViewN/AView Earnings Details
1/31/2012$0.47$0.50ViewN/AView Earnings Details
11/1/2011$0.55$0.62ViewN/AView Earnings Details
8/2/2011$0.59$0.60ViewN/AView Earnings Details
5/3/2011$0.59$0.60ViewN/AView Earnings Details
2/1/2011$0.46$0.47ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Pfizer (NYSE:PFE)
Current Year EPS Consensus Estimate: $2.46 EPS
Next Year EPS Consensus Estimate: $2.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.54$0.56$0.55
Q2 20164$0.56$0.63$0.61
Q3 20163$0.57$0.62$0.60
Q4 20163$0.51$0.58$0.55
(Data provided by Zacks Investment Research)


Current Dividend Information for Pfizer (NYSE:PFE)
Annual Dividend:$1.20
Dividend Yield:3.45%
Payout Ratio:95.24% (Based on Trailing 12 Months of Earnings)
48.78% (Based on Current Year Consensus EPS Estimate)
45.11% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:8.40% (3 Year Average)

Dividend History for Pfizer (NYSE:PFE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Pfizer (NYSE:PFE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2016Frank A DamelioEVPSell100,000$34.49$3,449,000.00View SEC Filing  
5/24/2016Loretta V CangialosiVPSell86,000$33.97$2,921,420.00View SEC Filing  
5/11/2016Laurie J OlsonEVPSell4,700$33.50$157,450.00View SEC Filing  
5/10/2016Frank A DamelioEVPSell192,000$33.66$6,462,720.00View SEC Filing  
5/10/2016John D YoungInsiderSell41,700$33.53$1,398,201.00View SEC Filing  
5/9/2016Anthony J MaddalunaEVPSell8,950$33.75$302,062.50View SEC Filing  
5/9/2016Ian C ReadCEOSell275,000$33.80$9,295,000.00View SEC Filing  
5/5/2016Sally SusmanEVPSell76,116$33.75$2,568,915.00View SEC Filing  
5/4/2016Douglas M LanklerEVPSell29,700$33.69$1,000,593.00View SEC Filing  
5/4/2016Mikael DolstenInsiderSell67,588$33.46$2,261,494.48View SEC Filing  
5/3/2016Frank A DamelioEVPSell87,079$33.65$2,930,208.35View SEC Filing  
10/6/2015Pfizer Incmajor shareholderBuy714,285$7.00$4,999,995.00View SEC Filing  
6/11/2015Laurie J OlsonEVPSell26,000$34.39$894,140.00View SEC Filing  
3/12/2015Sally SusmanEVPSell46,179$34.00$1,570,086.00View SEC Filing  
2/13/2015Loretta V CangialosiVPSell104,000$34.73$3,611,920.00View SEC Filing  
2/12/2015Anthony J MaddalunaEVPSell9,000$34.85$313,650.00View SEC Filing  
2/11/2015Frank A DamelioEVPSell14,800$34.30$507,640.00View SEC Filing  
2/10/2015Anthony J MaddalunaEVPSell9,000$33.78$304,020.00View SEC Filing  
12/8/2014Anthony J MaddalunaEVPSell6,500$32.00$208,000.00View SEC Filing  
11/10/2014Charles H HillEVPSell8,285$30.18$250,041.30View SEC Filing  
11/7/2014John D YoungInsiderSell21,600$29.89$645,624.00View SEC Filing  
10/29/2014Anthony J MaddalunaEVPSell2,425$29.56$71,683.00View SEC Filing  
6/12/2014Laurie J OlsonEVPSell36,275$29.53$1,071,200.75View SEC Filing  
6/2/2014Geno J GermanoInsiderSell30,000$29.68$890,400.00View SEC Filing  
3/17/2014John YoungInsiderSell9,000$31.38$282,420.00View SEC Filing  
3/4/2014Loretta CangialosiVPSell102,943$32.05$3,299,323.15View SEC Filing  
3/4/2014Mikael DolstenInsiderSell35,789$32.58$1,166,005.62View SEC Filing  
3/4/2014Sally SusmanEVPSell67,585$32.59$2,202,595.15View SEC Filing  
1/13/2014Frank DamelioEVPSell131,810$30.82$4,062,384.20View SEC Filing  
11/1/2013Anthony J MaddalunaEVPSell43,500$31.02$1,349,370.00View SEC Filing  
11/1/2013Loretta V CangialosiVPSell10,000$31.20$312,000.00View SEC Filing  
10/28/2013Ian C ReadCEOSell338,000$30.57$10,332,660.00View SEC Filing  
9/16/2013Freda Lewis-HallEVPSell38,461$28.70$1,103,830.70View SEC Filing  
7/31/2013Charles H HillEVPSell96,500$29.64$2,860,260.00View SEC Filing  
7/31/2013Loretta V CangialosiVPSell14,688$29.63$435,205.44View SEC Filing  
5/15/2013Amy W SchulmanEVPSell70,000$29.36$2,055,200.00View SEC Filing  
5/15/2013Ian C ReadCEOSell69,900$29.39$2,054,361.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Pfizer (NYSE:PFE)
News IconWhy Pfizer Inc Stock Looks Set For A Good Run In 2016 (NYSE:PFE) - August 27 at 11:02 AM
News IconWorth Watching Stocks to Track: Pfizer Inc. (NYSE:PFE), Apple Inc. (NASDAQ:AAPL) - NYSE Journal (press release) (NYSE:PFE) - August 26 at 6:32 PM logoCan Novartis Tide Over the Alcon Crisis? (NYSE:PFE) - August 26 at 6:32 PM logo3 Top Stocks For Retirees (NYSE:PFE) - August 26 at 9:45 AM logoGame On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move) (NYSE:PFE) - August 26 at 8:24 AM logoWill Pfizer Take a Beating After Its Celebrex Settlement? (NYSE:PFE) - August 25 at 6:50 PM logoMedivation Inc (MDVN) Downgraded to Neutral on Pfizer Inc. (PFE) Deal - TCC (NYSE:PFE) - August 25 at 11:55 AM
News IconHC Stocks News Ring: Celgene Corporation (CELG), Pfizer Inc. (PFE) - share market updates (press release) (NYSE:PFE) - August 25 at 11:55 AM logoPfizer (PFE) Enters Agreement to Acquire AstraZeneca's (AZN) Small Molecule Anti-Infective Business in ~$1.58B Deal (NYSE:PFE) - August 24 at 6:33 PM logoPfizer-Medivation Deal: Good Or Bad For Shareholders? (NYSE:PFE) - August 24 at 6:33 PM logoPfizer’s Spending Spree Continues with a $725 Million Antibiotics Acquisition (NYSE:PFE) - August 24 at 6:33 PM logoPfizer to buy antibiotics business from AstraZeneca (NYSE:PFE) - August 24 at 6:33 PM logoPfizer Buys Part of AstraZeneca’s Antibiotics Business (NYSE:PFE) - August 24 at 6:33 PM logoPortfolio Manager: Is Pfizer Acquiring Too Quickly? (NYSE:PFE) - August 24 at 6:33 PM logoPfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep? (NYSE:PFE) - August 24 at 3:45 PM logoPfizer on Buying Spree With AstraZeneca Antibiotics Deal - New York Times (NYSE:PFE) - August 24 at 2:24 PM logoRisk Arbitrage Trading Strategies (NYSE:PFE) - August 24 at 12:56 PM logoPfizer acquires anti-invectives from AstraZeneca (NYSE:PFE) - August 24 at 12:56 PM logoPFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business (NYSE:PFE) - August 24 at 11:09 AM logoPFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business (NYSE:PFE) - August 24 at 10:45 AM logoPfizer's Spending Spree Continues with a $725 Million Antibiotics Acquisition - ETF Daily News (NYSE:PFE) - August 24 at 9:50 AM
News IconTraders Alert on Worth Watching Stocks: Pfizer Inc. (NYSE:PFE), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - NYSE Journal (press release) (NYSE:PFE) - August 24 at 9:50 AM logoAstraZeneca to sell molecule antibiotics business to Pfizer (NYSE:PFE) - August 24 at 9:50 AM
News IconPfizer grabs AZ antibiotics in $1.5B deal. Pre-split prep or just another sales-boosting buy? - FiercePharma (NYSE:PFE) - August 24 at 9:43 AM
News IconIt didn't get the whole package, but Pfizer will pay $1.5B for AZ's antibiotics biz - FierceBiotech (NYSE:PFE) - August 24 at 6:57 AM logoUPDATE 1-Pfizer to buy antibiotics business from AstraZeneca (NYSE:PFE) - August 24 at 4:40 AM logoPfizer to buy antibiotics business from AstraZeneca - Reuters (NYSE:PFE) - August 24 at 3:55 AM logoPfizer to buy AstraZeneca antibiotics business for up to $1.575B (NYSE:PFE) - August 24 at 3:18 AM logoAstraZeneca to sell antibiotics business to Pfizer (NYSE:PFE) - August 24 at 2:55 AM
News IconDrug-Makers At Considerable Level- Sanofi (NYSE:SNY), Pfizer Inc. (NYSE:PFE) - Seneca Globe (NYSE:PFE) - August 23 at 6:55 PM
News IconPfizer’s Latest Buyout Is No Reason for Investors to Cheer (NYSE:PFE) - August 23 at 11:17 AM logoAnalysts Give Their Two Cents on Medivation Inc (MDVN) and Pfizer Inc. (PFE) Following Acquisition News (NYSE:PFE) - August 23 at 11:17 AM logo23andMe Gene Database Receives Increased Demand Following Pfizer Inc. (NYSE:PFE) Use (NYSE:PFE) - August 23 at 11:17 AM
News IconPfizer Inc. (PFE) Acquires Medivation Inc. For $14 Billion (NYSE:PFE) - August 23 at 11:17 AM
News IconPfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaring (NYSE:PFE) - August 23 at 11:17 AM logoTop 10 Shareholders of Pfizer (PFE) (NYSE:PFE) - August 23 at 11:17 AM logoStock Market News for August 23, 2016 (NYSE:PFE) - August 23 at 11:17 AM logoWill Anda Acquisition Improve Access to Teva’s Generic Drugs? (NYSE:PFE) - August 23 at 11:17 AM logoWhat Pfizer Gets in Its $14 Billion Medivation Deal (NYSE:PFE) - August 23 at 8:21 AM logoPfizer to Acquire Key Drug -- WSJ - Nasdaq (NYSE:PFE) - August 23 at 4:21 AM logoPfizer walks away from $118 billion AstraZeneca takeover fight (NYSE:PFE) - August 23 at 1:49 AM logoThe $150 million winner — and the losers — in Pfizer's $14 billion takeout of Medivation (NYSE:PFE) - August 22 at 11:42 PM logoBenzinga's M&A Chatter for Monday August 22, 2016 (NYSE:PFE) - August 22 at 7:34 PM logoPfizer Inc. (PFE) Medivation Inc (MDVN) Deal; BMO Remains "Neutral to Positive" - TCC (NYSE:PFE) - August 22 at 6:45 PM logoPfizer boosts cancer drug roster with $14 billion Medivation deal - Reuters (NYSE:PFE) - August 22 at 5:56 PM logoUPDATE 5-Pfizer boosts cancer drug roster with $14 bln Medivation deal (NYSE:PFE) - August 22 at 5:19 PM logoPfizer's Medivation buy seen prescribing more biotech M&A (NYSE:PFE) - August 22 at 4:54 PM logoPfizer buys cancer drug maker Medivation for $14 billion (NYSE:PFE) - August 22 at 4:37 PM logoMedivation Ovation: Pfizer Pays the Price for Growth (NYSE:PFE) - August 22 at 2:48 PM logoUPDATE 3-Pfizer boosts cancer drug roster with $14 bln Medivation deal (NYSE:PFE) - August 22 at 12:42 PM


Pfizer (NYSE:PFE) Chart for Saturday, August, 27, 2016

Last Updated on 8/27/2016 by Staff